Outcome Measures of Modified Constraint Induced Movement Therapy Versus Dual Task Training on Upper Extremity and Cognitive Functions in Patients With Hemiparesis

NCT ID: NCT06457022

Last Updated: 2024-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-10

Study Completion Date

2024-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

All stroke patients were assessed via isokinetic dynamometer, Montreal cognitive assessment scale (MOCA) and Fugl Myer Upper extremity (FMUE) before and after the treatment program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients were classified randomly into three equal groups, Study group A (GA) receiving modified constraint induced movement therapy in addition to conventional physical therapy program, Study group B (GB) receiving dual task training in addition to conventional physical therapy program and control group C (GC) receiving only conventional physiotherapy program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiparesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
Double

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Receiving modified constraint induced movement therapy , for 30 minutes , in addition to conventional physiotherapy program for the other 30 minutes.

Group Type EXPERIMENTAL

Modified Constraint Induced Movement therapy

Intervention Type OTHER

patient wears a restraint instrument in his unaffected hand, then applying massed practice to his affected upper extremity. The patient wears padded glove in his unaffected upper extremity for restraining the patient from using his unaffected upper extremity for about 3 hours per day including the treatment session and the home program. So, by this way the patient is reinforced to use his affected upper extremity during this period of time to achieve his activities of daily living. Finally, the total time, the patient spends it during the day wearing the glove should be recorded each day.

Conventional physiotherapy rehabilitation program

Intervention Type OTHER

Ultrasound on shoulder. Graduated active exercises for shoulder. Prolonged stretching for spastic muscles

Group B

Receiving dual task training (Cognitive-Motor) for 30 minutes, in addition to conventional physiotherapy program for the other 30 minutes.

Group Type EXPERIMENTAL

Dual task training in the form of cognitive - motor task

Intervention Type OTHER

Verbal fluency: Ask the hemiparetic patient to title many words of specific type as fruits, vegetable or animals. Mental tracking: as the hemiparetic patient to subtract serial 3 between number 90 and 100.

Conventional physiotherapy rehabilitation program

Intervention Type OTHER

Ultrasound on shoulder. Graduated active exercises for shoulder. Prolonged stretching for spastic muscles

Group C

Receiving only conventional physiotherapy program for 60 minutes.

Group Type OTHER

Conventional physiotherapy rehabilitation program

Intervention Type OTHER

Ultrasound on shoulder. Graduated active exercises for shoulder. Prolonged stretching for spastic muscles

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modified Constraint Induced Movement therapy

patient wears a restraint instrument in his unaffected hand, then applying massed practice to his affected upper extremity. The patient wears padded glove in his unaffected upper extremity for restraining the patient from using his unaffected upper extremity for about 3 hours per day including the treatment session and the home program. So, by this way the patient is reinforced to use his affected upper extremity during this period of time to achieve his activities of daily living. Finally, the total time, the patient spends it during the day wearing the glove should be recorded each day.

Intervention Type OTHER

Dual task training in the form of cognitive - motor task

Verbal fluency: Ask the hemiparetic patient to title many words of specific type as fruits, vegetable or animals. Mental tracking: as the hemiparetic patient to subtract serial 3 between number 90 and 100.

Intervention Type OTHER

Conventional physiotherapy rehabilitation program

Ultrasound on shoulder. Graduated active exercises for shoulder. Prolonged stretching for spastic muscles

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with age range between 55 and 65 years old.
* The patients were from both genders (males \&females).
* Patients were of duration of illness between 6 and 12 months.
* The patients were scoring 1 \&1+ on modified Ashworth scale (mild spasticity).
* The patients were of good ability to see and hear.
* Consent form was obtained from all participants to approve the study and follow the commands.
* All patients were scoring more than 26 on MMSE. All patients were medically stable.

Exclusion Criteria

* patients with moderate and sever spasticity.
* patients with cognitive disorder due to other cause rather than spasticity.
* patients with unstable medical conditions.
* patients with previous or recurrent stroke.
* patients with respiratory problems.
* patients with shoulder dislocation or subluxation or frozen shoulder.
* patients with uncontrolled hypertension, diabetes mellitus, unstable angina or heart failure.
Minimum Eligible Age

55 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ahmed Alshimy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Alshimy

Lecturer of Physical Therapy for Neurology and it's Surgery

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al Ryada University for Science and Technology

Sadat, Menoufia, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intercostal Mulligan Moblization Post Mastectomy
NCT07181980 NOT_YET_RECRUITING NA